ğŸ’Š INTERVENTION OF THE WEEK: METFORMIN

A 100-year-old diabetes drug that may extend lifespan. Diabetics on metformin outlive non-diabetics not on it. The TAME trial aims to prove it.

Metformin was derived from French lilac (Galega officinalis), used medicinally since medieval times. It's been the first-line diabetes drug for decades. Now it's being investigated for longevity.

Longevity Mechanisms:

âš¡ AMPK Activation â€” Master metabolic switch
ğŸ¯ mTOR Inhibition â€” Mimics caloric restriction
ğŸ”¥ Reduced Inflammation â€” Lowers IL-6, CRP
ğŸ“‰ Lower Insulin/IGF-1 â€” Longevity-associated
ğŸ¦  Microbiome Effects â€” Beneficial changes
ğŸ§¬ Epigenetic Modifications â€” Slows epigenetic aging
ğŸ”‹ Mitochondrial Complex I â€” Mild inhibition, hormetic
ğŸ—ï¸ Reduced Cancer Risk â€” Consistent finding

Key Evidence:

ğŸ“Š UK Study (2014): Type 2 diabetics on metformin lived LONGER than matched non-diabetics. This shouldn't happenâ€”diabetes shortens life.

ğŸ“Š Multiple studies show 20-30% reduced cancer incidence in metformin users.

ğŸ“Š TAME Trial (ongoing): Testing metformin vs. placebo in healthy 65-79 year olds for effects on aging-related diseases.

Dosing for Longevity:

Typical: 500-1000mg, 1-2x daily
Extended-release better tolerated
Take with food to reduce GI side effects

Considerations:

âš ï¸ May blunt some exercise adaptations (hypertrophy)
âš ï¸ Depletes B12 (supplement recommended)
âš ï¸ GI side effects common initially
âš ï¸ Not ideal for athletes focused on muscle building

The bottom line: Metformin is the closest thing we have to a proven, widely available longevity drug. Cheap, safe, 60+ years of human data.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#InterventionOfTheWeek #Metformin #Longevity #AntiAging #TAME #Bioscope
